Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 4Phase 1 4Phase NA 3Phase 3 2

Status

Completed 16Recruiting 9Terminated 4Unknown 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Lymphoid 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Neoplasms 281Carcinoma, Non-Small-Cell Lung 251Leukemia, Myeloid, Acute 189Breast Neoplasms 151Melanoma 150Neoplasm Metastasis 148Multiple Myeloma 127Recurrence 123Colorectal Neoplasms 119Lymphoma, Non-Hodgkin 113Lymphoma 112Leukemia, Lymphocytic, Chronic, B-Cell 107Pancreatic Neoplasms 99Ovarian Neoplasms 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 91Leukemia 85Prostatic Neoplasms 83Lung Neoplasms 81Lymphoma, Large B-Cell, Diffuse 77Squamous Cell Carcinoma of Head and Neck 76Glioblastoma 73Carcinoma, Renal Cell 72Myelodysplastic Syndromes 67Lymphoma, Follicular 65Brain Neoplasms 60Lymphoma, Mantle-Cell 55Sarcoma 53Stomach Neoplasms 52Head and Neck Neoplasms 52Triple Negative Breast Neoplasms 49

Interventions

spartalizumab 1dostarlimab 1Ramucirumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Digestive System Neoplasms × Clear all
NCT05639153 2026-04-13

A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors

Zhejiang Doer Biologics Co., Ltd.

Phase 1 Terminated
13 enrolled
Gastrointestinal

Digestive System Neoplasms

NCT05980416 2025-11-14

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Elevation Oncology

Phase 1 Terminated
88 enrolled 18 charts
Gastrointestinal

Adenocarcinoma, Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms

NCT04171141 2025-01-16

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Pfizer

Phase 1 Terminated
79 enrolled 42 charts
Gastrointestinal

Digestive System Neoplasms, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02602067 2018-09-18

Tenatumomab

sigma-tau i.f.r. S.p.A.

Phase 1 Terminated
2 enrolled
BreastDermatologicGastrointestinalHead & NeckLymphoid

Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Lymphoma, Non-Hodgkin, Pancreatic Neoplasms, Respiratory Tract Neoplasms, Skin Neoplasms, Urogenital Neoplasms, Neoplasms, Connective and Soft Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡